127 related articles for article (PubMed ID: 18473227)
1. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
Liu K; Sun J; Wang Y; He Y; Gao K; He Z
Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
5. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and characterization of hydroxycamptothecin nanoparticles of amphiphilic block copolymer].
Xi N; Hou LB
Zhong Yao Cai; 2009 Apr; 32(4):604-7. PubMed ID: 19645250
[TBL] [Abstract][Full Text] [Related]
8. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK
Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576
[TBL] [Abstract][Full Text] [Related]
10. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
Xi N; Hou LB
Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-hydroxycamptothecin loaded PLA microbubbles.
Hou Z; Li L; Zhan C; Zhu P; Chang D; Jiang Q; Ye S; Yang X; Li Y; Xie L; Zhang Q
Ultrasonics; 2012 Sep; 52(7):836-41. PubMed ID: 22542992
[TBL] [Abstract][Full Text] [Related]
13. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
[TBL] [Abstract][Full Text] [Related]
14. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
15. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
Negi LM; Jaggi M; Talegaonkar S
Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
[TBL] [Abstract][Full Text] [Related]
16. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
Wang Z; Wang J; Yang S; Hou S
Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
18. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of 10-hydroxycamptothecin semisolid lipid nanoparticles and investigation of its stability].
Xi N; Hou LB; Yan XQ; Jiang QF; Wang CX
Zhong Yao Cai; 2006 Jan; 29(1):63-6. PubMed ID: 16722323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
